Literature DB >> 8609654

After initial setback, IL-12 regaining popularity.

S Jenks.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8609654     DOI： 10.1093/jnci/88.9.576

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

Authors:  Sumia Ali; Gwendalyn D King; James F Curtin; Marianela Candolfi; Weidong Xiong; Chunyan Liu; Mariana Puntel; Queng Cheng; Jesus Prieto; Antoni Ribas; Jerzy Kupiec-Weglinski; Nico van Rooijen; Hans Lassmann; Pedro R Lowenstein; Maria G Castro
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 2.  Localized Interleukin-12 for Cancer Immunotherapy.

Authors:  Khue G Nguyen; Maura R Vrabel; Siena M Mantooth; Jared J Hopkins; Ethan S Wagner; Taylor A Gabaldon; David A Zaharoff
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

3.  Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

Authors:  Masanori Matsui; Osamu Moriya; Maria Laura Belladonna; Sadahiro Kamiya; François A Lemonnier; Takayuki Yoshimoto; Toshitaka Akatsuka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 4.  Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy.

Authors:  Hong-My Nguyen; Kirsten Guz-Montgomery; Dipongkor Saha
Journal:  Cells       Date:  2020-02-10       Impact factor: 6.600

5.  Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.

Authors:  Bradley N Mills; Kelli A Connolly; Jian Ye; Joseph D Murphy; Taylor P Uccello; Booyeon J Han; Tony Zhao; Michael G Drage; Aditi Murthy; Haoming Qiu; Ankit Patel; Nathania M Figueroa; Carl J Johnston; Peter A Prieto; Nejat K Egilmez; Brian A Belt; Edith M Lord; David C Linehan; Scott A Gerber
Journal:  Cell Rep       Date:  2019-10-08       Impact factor: 9.423

Review 6.  Analysis of potential biomarkers of response to IL-12 therapy.

Authors:  Emily Schwarz; William E Carson
Journal:  J Leukoc Biol       Date:  2022-07-04       Impact factor: 6.011

7.  Gemini Cationic Lipid-Type Nanovectors Suitable for the Transfection of Therapeutic Plasmid DNA Encoding for Pro-Inflammatory Cytokine Interleukin-12.

Authors:  Natalia Sánchez-Arribas; María Martínez-Negro; Clara Aicart-Ramos; Conchita Tros de Ilarduya; Emilio Aicart; Andrés Guerrero-Martínez; Elena Junquera
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

8.  Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12.

Authors:  Fang Wei; Huiping Wang; Jufeng Zhang; Xiafang Chen; Chuanyuan Li; Qian Huang
Journal:  J Exp Clin Cancer Res       Date:  2013-01-26

Review 9.  Interleukin 12: still a promising candidate for tumor immunotherapy?

Authors:  Witold Lasek; Radosław Zagożdżon; Marek Jakobisiak
Journal:  Cancer Immunol Immunother       Date:  2014-02-11       Impact factor: 6.968
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.